证券记录 · 已归档季度
IONS
Ionis Pharmaceuticals, Inc. · Healthcare · Biotechnology
16被追踪持有人
-1Δ持有人
34.86M持有股份
$1.40B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -5.9% ·
股份流向 +30.0% ·
净新建仓位 -6.2%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +2 | 148.59M | $11.08B | +6 | −3 |
| Q1 2026 | 139 | -2 | 142.62M | $9.86B | +6 | −9 |
| Q4 2025 | 142 | 0 | 143.10M | $10.36B | +1 | — |
| Q3 2025 | 25 | +4 | 95.56M | $6.25B | +5 | −2 |
| Q2 2025 | 19 | +1 | 95.25M | $3.76B | +1 | — |
| Q1 2025 | 15 | -1 | 43.90M | $1.32B | +1 | −2 |
| Q4 2024 | 16 | -1 | 43.25M | $1.51B | — | −1 |
| Q3 2024 | 16 | -1 | 34.86M | $1.40B | — | −1 |
| Q2 2024 | 17 | — | 24.68M | $1.18B | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Capital World Investors ✦ | 7.83M | +247.6% | $313.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 4.21M | +7.0% | $168.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 4.21M | +7.0% | $168.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Tweedy, Browne ✦ | 3.45M | 0.0% | $138.39M | 6.6% | Held | 2 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 2.67M | +7.4% | $106.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Geode Capital Management ✦ (被动) | 2.67M | +7.4% | $106.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Norges Bank ✦ (被动) | 2.03M | +98.9% | $81.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 1.92M | +1008.8% | $76.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | Marshall Wace ✦ | 1.92M | +1008.8% | $76.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 19 | ARK Investment Management ✦ | 1.38M | +1.7% | $55.45M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 919.08K | -10.6% | $36.82M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 500.00K | -37.5% | $20.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Millennium Management ✦ | 430.72K | +235.9% | $17.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 401.15K | -36.0% | $16.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 401.15K | -36.0% | $16.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 190.51K | -23.6% | $7.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 145.09K | -23.9% | $5.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 145.09K | -23.9% | $5.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | Baillie Gifford ✦ | 39.58K | -84.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | Baillie Gifford ✦ | 39.58K | -84.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | Baillie Gifford ✦ | 39.58K | -84.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Gotham Asset Management ✦ | 6.26K | 0.0% | $250,856 | 0.0% | Held | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Point72 Asset Management | $6.54M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 490 持有人, 170.17M 股份, $11.94B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据